ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 715643 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 715643; 2) Community: the network communities that were significantly associated with the response to NSC 715643; 3) Molecule: the relationships between components within communities and NSC 715643; 4) MDR: the compounds that were significantly associated with the NSC 715643.

NSC Compound Enrichment Correlation
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0222343516878698 0.22371242
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0244632509325736 0.41276377
NSC 290193 CYCLOSPORIN A 0.0244632509325736 0.032325279
NSC 317908 Null 0.0244632509325736 -0.04345304
NSC 685687 1,2,5,6,9-Pentaazadicylopent[a,b]indene-3,4(2H,5H)-dione,2,5-diphenyl- 0.0244632509325736 -0.077409758
NSC 720174 Null 0.0244632509325736 0.20585823
NSC 724600 S-(dimethylarsino)-3-mercapto-1,2-propyl diacetate 0.0244632509325736 0.024031371
NSC 730563 Miliusane A 0.0244632509325736 -0.046320621
NSC 736164 pyrazoline derivative 0.0244632509325736 0.0040127893
NSC 143019 METHANEDIAMINE, N,N'-BIS(1,3,4-THIADIAZOL-2-YL)- 0.0244718705444135 0.23423633
Total:34  Current:15    [First] [Prev] [Next] [Last]